2-176093061-GGCGGCGGCGGCAGCGGCGGCT-GGCGGCGGCGGCAGCGGCGGCTGCGGCGGCGGCAGCGGCGGCT
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP3
The NM_000523.4(HOXD13):c.183_203dup(p.Ala65_Ala71dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000033 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
HOXD13
NM_000523.4 inframe_insertion
NM_000523.4 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.39
Genes affected
HOXD13 (HGNC:5136): (homeobox D13) This gene belongs to the homeobox family of genes. The homeobox genes encode a highly conserved family of transcription factors that play an important role in morphogenesis in all multicellular organisms. Mammals possess four similar homeobox gene clusters, HOXA, HOXB, HOXC and HOXD, located on different chromosomes, consisting of 9 to 11 genes arranged in tandem. This gene is one of several homeobox HOXD genes located in a cluster on chromosome 2. Deletions that remove the entire HOXD gene cluster or the 5' end of this cluster have been associated with severe limb and genital abnormalities. Mutations in this particular gene cause synpolydactyly. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 2-176093061-G-GGCGGCGGCGGCAGCGGCGGCT is Pathogenic according to our data. Variant chr2-176093061-G-GGCGGCGGCGGCAGCGGCGGCT is described in ClinVar as [Pathogenic]. Clinvar id is 1919465.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP3
Nonframeshift variant in repetitive region in NM_000523.4
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HOXD13 | NM_000523.4 | c.183_203dup | p.Ala65_Ala71dup | inframe_insertion | 1/2 | ENST00000392539.4 | NP_000514.2 | |
HOXD13 | XM_011511068.3 | c.725-1407_725-1387dup | intron_variant | XP_011509370.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HOXD13 | ENST00000392539.4 | c.183_203dup | p.Ala65_Ala71dup | inframe_insertion | 1/2 | 1 | NM_000523.4 | ENSP00000376322 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000327 AC: 4AN: 1224358Hom.: 0 Cov.: 31 AF XY: 0.00000334 AC XY: 2AN XY: 598710
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
4
AN:
1224358
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
598710
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this variant affects HOXD13 function (PMID: 32386547). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 1919465). This variant has been observed in individuals with HOXD13-related conditions (PMID: 19686284, 24343878). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This variant, c.183_203dup, results in the insertion of 7 amino acid(s) of the HOXD13 protein (p.Ala65_Ala71dup), but otherwise preserves the integrity of the reading frame. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 27, 2023 | Published functional studies demonstrate that poly-alanine repeat expansions in HOXA13 result in protein misfolding, degradation, and cytoplasmic aggregation (PMID: 15333588); In-frame insertion of 7 amino acids in a non-repeat region predicted to critically alter the protein; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 34094714, 15333588) - |
HOXD13-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Nov 28, 2023 | Variant summary: HOXD13 c.183_203dup21 (p.Ala65_Ala71dup), also annotated as c.172_192dup21 (p.Ala58_Ala64dup), results in an in-frame duplication that is predicted to expand a polyalanine repeat region by 7 amino acids in the encoded protein. The variant was absent in 21698 control chromosomes (gnomAD). c.183_203dup21 has been reported in the literature in multiple individuals affected with limb malformations including polydactyly, syndactyly, or clinodactyly (Sun_2021, Chen_2023), and was found to cosegregate with disease. These data indicate that the variant is very likely to be associated with disease. A mouse model with the same length of alanine expansion due to a 21-bp duplication shows digital malformations (Bruneau_2001). An analysis of alanine expansions of different lengths found that the +7A expansion alters the composition and properties of HOXD13-containing condensates in vivo and in vitro (Basu_2020), suggesting that altered phase separation may disrupt the transcription factor's ability to co-condense with transcriptional coactivators. The following publications have been ascertained in the context of this evaluation (PMID: 34094714, 37035736, 32386547, 11543619). One submitter has cited a clinical-significance assessment for this variant to ClinVar after 2014 and has classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at